UNSPSC 51292907: Imipramine or melipramine or prazepine

This classification denotes a tricyclic antidepressant with the molecular formula C19H24N2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier OGG85SX4E4, chemically known as 5,6-dihydro-n-(3-(dimethylamino)propyl)-11h-dibenz(b,e)azepine but generally known as imipramine, which bears US NIH Compound Identifier 3696. European Medicines Agency schedules Imipramine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08152MIG.

UNSPSC 51292907 Imipramine or melipramine or prazepine (Commodity) does not reflect the work actually being solicited under this code at the state and local level. The single recent opportunity on record is Seminole County, Florida's IFB 60459723LAS, posted June 30, 2026, which procures naloxone and safe drug deactivation systems — pharmaceutical harm-reduction equipment entirely outside the scope of tricyclic antidepressants. The mismatch suggests a cataloging error in how the county tagged the solicitation or a misalignment between the UNSPSC taxonomy and the vendor database serving state and local procurement platforms.

No recent state and local procurement activity supports legitimate buying under this Commodity code. Without additional opportunities demonstrating actual demand for imipramine, melipramine, or prazepine at state or local level, the code shows no actionable market signal for business development purposes.